172 related articles for article (PubMed ID: 15703952)
1. Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
Denko CW; Malemud CJ
Rheumatol Int; 2006 Feb; 26(4):292-7. PubMed ID: 15703952
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH).
Denko CW; Boja B; Malemud CJ
Front Biosci; 2002 Apr; 7():a37-43. PubMed ID: 11897552
[TBL] [Abstract][Full Text] [Related]
3. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis--insulin, insulin-like growth factor-I, growth hormone.
Denko CW; Boja B; Moskowitz RW
J Rheumatol; 1994 Sep; 21(9):1725-30. PubMed ID: 7799357
[TBL] [Abstract][Full Text] [Related]
4. Impaired insulin secretion and uptake in patients with diffuse idiopathic skeletal hyperostosis.
Eckertova M; Krskova K; Penesova A; Radikova Z; Zlnay D; Rovensky J; Zorad S
Endocr Regul; 2009 Oct; 43(4):149-55. PubMed ID: 19908933
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis.
Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M
Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945
[TBL] [Abstract][Full Text] [Related]
6. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
7. Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders.
Denko CW; Boja B; Moskowitz RW
Osteoarthritis Cartilage; 1996 Dec; 4(4):245-9. PubMed ID: 11048621
[TBL] [Abstract][Full Text] [Related]
8. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
Gleeson HK; Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
[TBL] [Abstract][Full Text] [Related]
10. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
11. Serum adiponectin levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
Mader R; Novofastovski I; Schwartz N; Rosner E
Clin Rheumatol; 2018 Oct; 37(10):2839-2845. PubMed ID: 30121711
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
14. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
[TBL] [Abstract][Full Text] [Related]
15. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
16. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
[TBL] [Abstract][Full Text] [Related]
17. Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children.
Woelfle JF; Harz K; Roth C
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):17-23. PubMed ID: 17286229
[TBL] [Abstract][Full Text] [Related]
18. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
19. Intra-erythrocyte deposition of growth hormone in rheumatic diseases.
Denko CW; Boja B; Malemud CJ
Rheumatol Int; 2003 Jan; 23(1):11-4. PubMed ID: 12548436
[TBL] [Abstract][Full Text] [Related]
20. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
